Antidepressants during pregnancy: Guideline adherence and current practice amongst Dutch gynaecologists and midwives

Midwifery

Volumn 61, Issue , 2018, Pages 29-35

  Molenaar, Nina M ^a   Brouwer, Marlies E ^b   Duvekot, Johannes J ^a   Burger, Huibert ^c   Knijff, Esther M ^a   Hoogendijk, Witte J ^a   Bockting, Claudi L H ^d   de Wolf, G S ^d   Lambregtse van den Berg, Mijke P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Antidepressive agents; Depression; Guideline adherence; Medication therapy management; Peripartum period; Pregnancy

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; FEMALE; GYNECOLOGY; HUMAN; MALE; MANPOWER; MIDDLE AGED; NETHERLANDS; NURSE MIDWIFE; PHYSICIAN; PREGNANCY; PRENATAL CARE; PROCEDURES; PROTOCOL COMPLIANCE; QUESTIONNAIRE; STANDARDS; STATISTICAL MODEL; TRENDS;

ADULT; ANTIDEPRESSIVE AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; GUIDELINE ADHERENCE; GYNECOLOGY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NETHERLANDS; NURSE MIDWIVES; PHYSICIANS; PRACTICE PATTERNS, PHYSICIANS'; PREGNANCY; PRENATAL CARE; SURVEYS AND QUESTIONNAIRES;

EID: 85042928506     PISSN: 02666138     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.midw.2018.02.018     Document Type: Article

References (36)

1. Amelink-Verburg, M.P., Buitendijk, S.E., Pregnancy and labour in the Dutch maternity care system: what is normal? The role division between midwives and obstetricians. Journal of Midwifery&Women's Health 55 (2010), 216–225.
2. Andrade, S.E., Raebel, M.A., Brown, J., et al. Use of antidepressant medications during pregnancy: a multisite study. American Journal of Obstetrics and Gynecology, 198, 2008, 194 (e191-195).
3. Arts, D.L., Voncken, A.G., Medlock, S., Abu-Hanna, A., van Weert, H.C., Reasons for intentional guideline non-adherence: a systematic review. International Journal of Medical Informatics 89 (2016), 55–62.
4. Bakker, M.K., Kolling, P., van den Berg, P.B., de Walle, H.E., de Jong van den Berg, L.T., Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. British Journal of Clinical Pharmacology 65 (2008), 600–606.
5. Cantilino, A., Lorenzo, L., Paula Jdos, A., Einarson, A., Use of psychotropic medications during pregnancy: perception of teratogenic risk among physicians in two Latin American countries. Revista Brasileira de Psiquiatria 36 (2014), 106–110.
6. Charlton, R.A., Jordan, S., Pierini, A., et al. Selective serotonin reuptake inhibitor prescribing before, during and after pregnancy: a population-based study in six European regions. BJOG 122 (2015), 1010–1020.
7. Cohen, L.S., Altshuler, L.L., Harlow, B.L., et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 295 (2006), 499–507.
8. Croen, L.A., Grether, J.K., Yoshida, C.K., Odouli, R., Hendrick, V., Antidepressant use during pregnancy and childhood autism spectrum disorders. Archives of General Psychiatry 68 (2011), 1104–1112.
9. De Vera, M.A., Berard, A., Antidepressant use during pregnancy and the risk of pregnancy-induced hypertension. British Journal of Clinical Pharmacology 74 (2012), 362–369.
10. Field, T., Prenatal depression effects on early development: a review. Infant Behavior&Development 34 (2011), 1–14.
11. Fleuren, M., Grol, R., de Haan, M., Wijkel, D., Oudshoorn, C., Adherence by midwives to the Dutch national guidelines on threatened miscarriage in general practice: a prospective study. Quality in Health Care 6 (1997), 69–74.
12. Furu, K., Kieler, H., Haglund, B., et al. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design. BMJ, 350, 2015, h1798.
13. Gentile, S., Galbally, M., Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: a systematic review. Journal of Affective Disorders 128 (2011), 1–9.
14. Grigoriadis, S., VonderPorten, E.H., Mamisashvili, L., et al. The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis. Journal of Clinical Psychiatry 74 (2013), e309–e320.
15. Grigoriadis, S., VonderPorten, E.H., Mamisashvili, L., et al. Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence. Journal of Clinical Psychiatry 74 (2013), e293–e308.
16. Grote, N.K., Bridge, J.A., Gavin, A.R., Melville, J.L., Iyengar, S., Katon, W.J., A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Archives of General Psychiatry 67 (2010), 1012–1024.
17. Haagen, E.C., Nelen, W.L., Hermens, R.P., Braat, D.D., Grol, R.P., Kremer, J.A., Barriers to physician adherence to a subfertility guideline. Human Reproduction 20 (2005), 3301–3306.
18. Huybrechts, K.F., Bateman, B.T., Palmsten, K., et al. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA 313 (2015), 2142–2151.
19. Hviid, A., Melbye, M., Pasternak, B., Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. New England Journal of Medicine 369 (2013), 2406–2415.
20. Kenefick, H., Lee, J., Fleishman, V., Improving Physician Adherence To Clinical Practice Guidelines: Barriers and Strategies for Change. 2008, New England Healthcare Institute 〈http://www.nehi.net/writable/publication_files/file/cpg_report_final.pdf〉.
21. Kieler, H., Artama, M., Engeland, A., et al. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ, 344, 2012, d8012.
22. McElligott, J.T., Lemay, J.R., O'Brien, E.S., Roland, V.A., Basco, W.T., Roberts, J.R., Practice patterns and guideline adherence in the management of attention deficit/hyperactivity disorder. Clinical Pediatrics 53 (2014), 960–966.
23. Mistiaen P, Bloemendal, E., Weening, J. W., Harmsen, M., 2012. Guideline adherence in the Netherlands: a systematic review. G-I-N Conference. 〈 http://www.g-i-n.net/document-store/g-i-n-conferences/berlin-2012/orals/o57-mistiaen.pdf〉.
24. Molenaar, N.M, Brouwer, M.B., Bockting, C.L.H., et al. Stop or Go? Preventive cognitive therapy with guided tapering of antidepressants during pregnancy: study protocol of a pragmatic multicentre non-inferiority randomized controlled trial. BMC Psychiatry, 16, 2016, 72.
25. Nederlandse Vereniging voor Obstetrie en Gynaecologie (NVOG), 2012. Richtlijn: SSRI-gebruik in de zwangerschap en tijdens de lactatie. URL: 〈http://www.nvog-documenten.nl/uploaded/docs/SSRI%20gebruik%20in%20de%20zwangerschap%20en%20tijdens%20de%20lactatie%20definitief.pdf〉.
26. Osborn, E.H., Bird, J.A., McPhee, S.J., Rodnick, J.E., Fordham, D., Cancer screening by primary care physicians. Can we explain the differences?. Journal of Family Practice 32 (1991), 465–471.
27. Ross, L.E., Grigoriadis, S., Mamisashvili, L., et al. Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry 70 (2013), 436–443.
28. Rousseau, A., Rozenberg, P., Perrodeau, E., Deneux-Tharaux, C., Ravaud, P., Variations in postpartum hemorrhage management among midwives: a national vignette-based study. PLoS One, 11, 2016, e0152863.
29. Smolders, M., Laurant, M., Verhaak, P., et al. Which physician and practice characteristics are associated with adherence to evidence-based guidelines for depressive and anxiety disorders?. Medical Care 48 (2010), 240–248.
30. Talge, N.M., Neal, C., Glover, V., Early Stress, Translational Research and Prevention Science Network: Fetal and Neonatal Experience on Child and Adolescent Mental Health, Antenatal maternal stress and long-term effects on child neurodevelopment: how and why?. Journal of Child Psychology and Psychiatry 48 (2007), 245–261.
31. van Greuningen M, Batenburg, R., Hansen, J., 2010. The label market for gynaecologists in the Netherlands. The situation in 2009, with a need estimate to 2027. NIVEL. URL 〈 https://www.nivel.nl/sites/default/files/bestanden/Rapport-de-arbeidsmarkt-voor-gynaecologen-in-Nederland.pdf〉.
32. van Hassel D.T.P., Kasteleijn, A., Kenens, R.J., 2015. Figures from the registration of midwives. Poll 2015. NIVEL. URL 〈 https://www.nivel.nl/sites/default/files/bestanden/Cijfers-uit-de-registratie-van-verloskundigen-peiling-jan-2015.pdf〉.
33. van Rijswijk, E., Borghuis, M., van de Lisdonk, E., Zitman, F., van Weel, C., Treatment of mental health problems in general practice: a survey of psychotropics prescribed and other treatments provided. International Journal of Clinical Pharmacology and Therapeuticsr 45 (2007), 23–29.
34. Ververs, T., Kaasenbrood, H., Visser, G., Schobben, F., de Jong-van den Berg, L., Egberts, T., Prevalence and patterns of antidepressant drug use during pregnancy. European Journal of Clinical Pharmacology 62 (2006), 863–870.
35. Ververs, T., van Dijk, L., Yousofi, S., Schobben, F., Visser, G.H., Depression during pregnancy: views on antidepressant use and information sources of general practitioners and pharmacists. BMC Health Services Research, 9, 2009, 119.
36. Yonkers, K.A., Gotman, N., Smith, M.V., et al. Does antidepressant use attenuate the risk of a major depressive episode in pregnancy?. Epidemiology 22 (2011), 848–854.